161 results
8-K
EX-10.2
AORT
Artivion Inc
30 Dec 14
Other Events
12:00am
of the foregoing, each Party will notify the other immediately if it becomes aware of any death or bodily injury caused by the Party’s Product.
5.6.3 … bodily injury caused by the Party’s Product); and (ii) deliver, within the permitted time periods, all annual or other periodic reports required
8-K
EX-10.2
AORT
Artivion Inc
18 Jan 12
Other Events
12:00am
the other immediately if it becomes aware of any death or bodily injury caused by the Party’s Product.
5.6.3 If either Party receives notice of an actual … within any relevant time periods all events that are required to be reported (including any death or serious bodily injury caused by the Party’s
8-K
EX-10.1
lujfbqnfdlew22g
27 Oct 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
a74s8j7ho9gpd os47
21 Apr 08
CryoLife To Distribute FDA-approved Hemostatic Agent Under Private Label
12:00am
8-K
EX-99.1
ile039kxzqb9ge7p58g9
11 Aug 03
Financial statements and exhibits
12:00am
425
EX-99.2
ler71
23 Feb 10
Business combination disclosure
12:00am
8-K
EX-99.2
byaoylji5
23 Feb 10
Important Information for Medafor Shareholders
12:00am
8-K
jdw dfiz0
5 Mar 10
Regulation FD Disclosure
12:00am
8-K
EX-10.1
s5u790z2x
30 Jan 12
Other Events
12:00am
424B3
14rlroon2r4
16 Jan 97
Prospectus supplement
12:00am
8-K
EX-99.1
y7nnj9yb
30 Apr 09
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
tgssbh22s3ximc
31 Jul 08
CryoLife’s Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
12:00am
8-K
EX-99.1
unrww25e5bh36kqh 8pa
19 Feb 09
CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
12:00am